Located in California, USA, Ionis is focused on the discovery and development of antisense drugs, targeting rare diseases. The company has more than 1300 patents.
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze